Receptor Selectivity 5-Amino 1MQ demonstrates high selectivity for NNMT, avoiding off-target effects: [3] Does NOT inhibit structurally related SAM-dependent methyltransferases: DNMT1, PRMT3, COMT Does NOT inhibit NAD+ pathway enzymes: NAMPT, SIRT1 This confirms that NAD+ and SAM increases result solely from preventing their degradation by NNMT, not from interfering with their synthesis or utilization enzymes
10.1016/j.amjmed.2003.09.046 46 RuckerR
Quinn E, Kuzawa C
No regulatory body Health Canada, the FDA, the EMA, the TGA, or any equivalent has approved BPC-157 as a drug for human or veterinary use
If youre shopping for the best BPC-157, here are a few key things to consider: Purity and testing: Look for products that are third-party tested with at least 98% purity and clear Certificates of Analysis (COAs)
Deep Dive: BPC-157 and the Nitric Oxide Pathway One of the most significant areas of recent research involves how BPC-157 interacts with the Nitric Oxide (NO) system